Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Oliver Zeitz

Showing results (81-90 of 99) with videos related to

Pageof 10
Sort By:
JAMA Ophthalmology|December 23, 2016
Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical TrialsCharles C Wykoff, Dennis M Marcus, Edoardo Midena, et al.
Ophthalmology|April 28, 2012
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edemaDiana V Do, Quan Dong Nguyen, David Boyer, et al.
Ophthalmology|October 3, 2013
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO StudyJean-François Korobelnik, Frank G Holz, Johann Roider, et al.
International Journal of Molecular Sciences|June 28, 2023
Systemic Blood Proteome Patterns Reflect Disease Phenotypes in Neovascular Age-Related Macular DegenerationSteffen E Künzel, Leonie T M Flesch, Dominik P Frentzel, et al.
British Journal of Clinical Pharmacology|October 21, 2018
The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trialAntonia M Joussen, Sebastian Wolf, Peter K Kaiser, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 6, 2024
AI-driven discovery of blood xenobiotic biomarkers in neovascular age-related macular degeneration using iterative random forestsSteffen E Künzel, Dominik P Frentzel, Leonie T M Flesch, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 9, 2017
Integrated results from the COPERNICUS and GALILEO studiesAmelie Pielen, W Lloyd Clark, David S Boyer, et al.
Ophthalmology. Retina|May 4, 2019
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME StudiesPaul Mitchell, Ian McAllister, Michael Larsen, et al.
Ophthalmology. Retina|May 4, 2019
Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVIDRishi P Singh, Charles C Wykoff, David M Brown, et al.
Ophthalmology Science|June 30, 2026
Tropomyosin-Related Kinase Receptor Type B Agonism in Geographic Atrophy-The Translational Challenges from Preclinical Data to a First-in-Human TrialDavid Brown, Oliver Zeitz, Clare Bailey, et al.
Pageof 10

Showing results (81-90 of 99) with videos related to

Sort By:
Pageof 10
JAMA Ophthalmology|December 23, 2016
Intravitreal Aflibercept Injection in Eyes With Substantial Vision Loss After Laser Photocoagulation for Diabetic Macular Edema: Subanalysis of the VISTA and VIVID Randomized Clinical TrialsCharles C Wykoff, Dennis M Marcus, Edoardo Midena, et al.
Ophthalmology|April 28, 2012
One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edemaDiana V Do, Quan Dong Nguyen, David Boyer, et al.
Ophthalmology|October 3, 2013
Intravitreal Aflibercept Injection for Macular Edema Resulting from Central Retinal Vein Occlusion: One-Year Results of the Phase 3 GALILEO StudyJean-François Korobelnik, Frank G Holz, Johann Roider, et al.
International Journal of Molecular Sciences|June 28, 2023
Systemic Blood Proteome Patterns Reflect Disease Phenotypes in Neovascular Age-Related Macular DegenerationSteffen E Künzel, Leonie T M Flesch, Dominik P Frentzel, et al.
British Journal of Clinical Pharmacology|October 21, 2018
The Developing Regorafenib Eye drops for neovascular Age-related Macular degeneration (DREAM) study: an open-label phase II trialAntonia M Joussen, Sebastian Wolf, Peter K Kaiser, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|June 6, 2024
AI-driven discovery of blood xenobiotic biomarkers in neovascular age-related macular degeneration using iterative random forestsSteffen E Künzel, Dominik P Frentzel, Leonie T M Flesch, et al.
Clinical Ophthalmology (Auckland, N.Z.)|September 9, 2017
Integrated results from the COPERNICUS and GALILEO studiesAmelie Pielen, W Lloyd Clark, David S Boyer, et al.
Ophthalmology. Retina|May 4, 2019
Evaluating the Impact of Intravitreal Aflibercept on Diabetic Retinopathy Progression in the VIVID-DME and VISTA-DME StudiesPaul Mitchell, Ian McAllister, Michael Larsen, et al.
Ophthalmology. Retina|May 4, 2019
Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVIDRishi P Singh, Charles C Wykoff, David M Brown, et al.
Ophthalmology Science|June 30, 2026
Tropomyosin-Related Kinase Receptor Type B Agonism in Geographic Atrophy-The Translational Challenges from Preclinical Data to a First-in-Human TrialDavid Brown, Oliver Zeitz, Clare Bailey, et al.
Pageof 10